Does ATEZOLIZUMAB Cause Therapy partial responder? 184 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 184 reports of Therapy partial responder have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.6% of all adverse event reports for ATEZOLIZUMAB.
184
Reports of Therapy partial responder with ATEZOLIZUMAB
0.6%
of all ATEZOLIZUMAB reports
53
Deaths
12
Hospitalizations
How Dangerous Is Therapy partial responder From ATEZOLIZUMAB?
Of the 184 reports, 53 (28.8%) resulted in death, 12 (6.5%) required hospitalization, and 9 (4.9%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 184 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which ATEZOLIZUMAB Alternatives Have Lower Therapy partial responder Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN